Harrow Health Stock Analysis

Harrow Stock Analysis Notes

About 16.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.13. Harrow Health had not issued any dividends in recent years. The entity had 1:5 split on the 8th of February 2013. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Harrow Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 182 people. To learn more about Harrow Health call Mark JD at 615 733 4730 or check out https://www.harrow.com.

Harrow Health Investment Alerts

Harrow Largest EPS Surprises

View All Earnings Estimates

Harrow Health Environmental, Social, and Governance (ESG) Scores

Harrow Stock Institutional Investors

Note, although Harrow Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Harrow Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.75 B.

Harrow Profitablity

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.

Management Efficiency

Harrow Health has return on total asset (ROA) of 0.0491 % which means that it generated a profit of $0.0491 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0957) %, meaning that it created substantial loss on money invested by shareholders. Harrow Health's management efficiency ratios could be used to measure how well Harrow Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 0.03 in 2026, whereas Return On Tangible Assets are likely to drop (0.08) in 2026. At this time, Harrow Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 229 M in 2026, whereas Return On Tangible Assets are likely to drop (0.08) in 2026.

Technical Drivers

As of the 5th of February, Harrow Health retains the Market Risk Adjusted Performance of 0.1777, downside deviation of 3.07, and Risk Adjusted Performance of 0.0858. Harrow Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Harrow Health variance and potential upside to decide if Harrow Health is priced fairly, providing market reflects its last-minute price of 47.2 per share. Given that Harrow Health has jensen alpha of 0.2797, we strongly advise you to confirm Harrow Health's regular market performance to make sure the company can sustain itself at a future point.

Harrow Health Price Movement Analysis

Harrow Health Insider Trading Activities

Harrow Health Outstanding Bonds

Harrow Health Predictive Daily Indicators

Harrow Health Corporate Filings

Harrow Health Forecast Models

Harrow Health's time-series forecasting models are one of many Harrow Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Harrow Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Harrow Health Debt to Cash Allocation

Harrow Health currently holds 228.83 M in liabilities. Harrow Health has a current ratio of 4.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Harrow Health's use of debt, we should always consider it together with its cash and equity.

Harrow Health Total Assets Over Time

Harrow Health Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Harrow Health uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Harrow Health Debt Ratio

64.0

It appears slightly above 36% of Harrow Health's assets are financed be debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Harrow Health's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Harrow Health, which in turn will lower the firm's financial flexibility.

Harrow Health Corporate Bonds Issued

Harrow Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Harrow Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Harrow shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Harrow Health. By using and applying Harrow Stock analysis, traders can create a robust methodology for identifying Harrow entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Harrow analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Harrow analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Harrow Health stock analysis indicators help investors evaluate how Harrow Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Harrow Health shares will generate the highest return on investment. By understating and applying Harrow Health stock analysis, traders can identify Harrow Health position entry and exit signals to maximize returns.

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.